vTv Therapeutics to Present Full Clinical Study Results from the Positive Phase 2 Simplici-T1 Study of TTP399\, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes at the ADA’s 80th Virtual Scientific Sessions